Leukocyte function antigen-1 (LFA-1) antagonist (Actinobac Biomed)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameLeukocyte function antigen-1 (LFA-1) antagonist (Actinobac Biomed)
Drug Alias NameLeukothera
ClassificationBiologics
Mechanisms of ActionLeukocyte adhesion glycoprotein LFA-1 alpha antagonists
TargetsLeukocyte adhesion glycoprotein LFA-1 alpha
Therapy Area/IndicationsAutoimmune DiseasesPsoriasisHematologic Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesActinobac BiomedUniversity Of Medicine & Dentistry Of New Jersey
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesActinobac BiomedUniversity Of Medicine & Dentistry Of New Jersey
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesPsoriasisHematologic Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksN/A